Publication:
Liposomes as potential nanocarriers for theranostic applications in chronic inflammatory lung diseases

dc.contributor.departmentKUTTAM (Koç University Research Center for Translational Medicine)
dc.contributor.departmentGraduate School of Health Sciences
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorBayram, Hasan
dc.contributor.kuauthorSüer, Hande
dc.contributor.schoolcollegeinstituteGRADUATE SCHOOL OF HEALTH SCIENCES
dc.contributor.schoolcollegeinstituteResearch Center
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T13:50:22Z
dc.date.issued2017
dc.description.abstractChronic obstructive pulmonary disease and asthma affect millions of people worldwide. Conventional treatments are not sufficient at preventing the progression of these diseases. The treatments are unspecific, and when administered systematically, and in high doses, they have adverse health effects. Further, the current diagnostic methods are poor and they are not capable of identifying the accurate state of the disease. Nanoparticle-based theranostics (NBTs) are well-established systems that simultaneously provide treatment and diagnostics. Various nanocarriers can be used in NBT and are designed according to the need. In this review, liposome-based theranostic systems are evaluated and possible modifications that could provide better drug delivery and accumulation and diagnosis are exemplified. These systems can be applied to conventional therapeutics to avoid side effects and perhaps overcome the challenges that interfere with their cellular accumulation.
dc.description.fulltextYES
dc.description.indexedbyScopus
dc.description.issue1
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipN/A
dc.description.versionPublisher version
dc.description.volume1
dc.identifier.doi10.4103/bbrj.bbrj_54_17
dc.identifier.embargoNO
dc.identifier.filenameinventorynoIR02217
dc.identifier.issn2588-9834
dc.identifier.quartileN/A
dc.identifier.scopus2-s2.0-85084598990
dc.identifier.urihttps://hdl.handle.net/20.500.14288/3907
dc.keywordsAsthma
dc.keywordsChronic obstructive pulmonary disease
dc.keywordsImaging
dc.keywordsLiposomes
dc.keywordsMagnetic resonance imaging
dc.keywordsSuperparamagnetic iron oxide nanoparticle
dc.keywordsTheranostics
dc.language.isoeng
dc.publisherMedknow Publications
dc.relation.grantnoNA
dc.relation.ispartofBiomedical and Biotechnology Research Journal
dc.relation.urihttp://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/8876
dc.subjectMedicine
dc.subjectDry powder inhaler
dc.subjectSpray drying
dc.subjectInhalation
dc.titleLiposomes as potential nanocarriers for theranostic applications in chronic inflammatory lung diseases
dc.typeReview
dspace.entity.typePublication
local.contributor.kuauthorSüer, Hande
local.contributor.kuauthorBayram, Hasan
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit1GRADUATE SCHOOL OF HEALTH SCIENCES
local.publication.orgunit1Research Center
local.publication.orgunit2KUTTAM (Koç University Research Center for Translational Medicine)
local.publication.orgunit2School of Medicine
local.publication.orgunit2Graduate School of Health Sciences
relation.isOrgUnitOfPublication91bbe15d-017f-446b-b102-ce755523d939
relation.isOrgUnitOfPublication2f870f28-12c9-4b28-9465-b91a69c1d48c
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscovery91bbe15d-017f-446b-b102-ce755523d939
relation.isParentOrgUnitOfPublication4c75e0a5-ca7f-4443-bd78-1b473d4f6743
relation.isParentOrgUnitOfPublicationd437580f-9309-4ecb-864a-4af58309d287
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery4c75e0a5-ca7f-4443-bd78-1b473d4f6743

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
8876.pdf
Size:
401.44 KB
Format:
Adobe Portable Document Format